Cancer drug by-product may be an untapped Parkinson’s treatment
A new study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties. When combined with the original drug, the by-product produced a synergistic effect to inhibit prostate cancer cells; when used alone, it reduced the buildup of a toxic protein in the brain associated with Parkinson’s disease.
Tags: metabolism, Drug, Prostate cancer, Parkinson’s Disease
Continue reading Cancer drug by-product may be an untapped Parkinson’s treatment